Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeting STAT3 affects melanoma on multiple fronts.

Marcin Kortylewski1, Richard Jove, Hua Yu

  • 1Immunology Program, USA.

Cancer Metastasis Reviews
|June 30, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transcription factor YY1 inhibits the expression of THY1 to promote interstitial pulmonary fibrosis by activating the HSF1/miR-214 axis.

Aging·2020
Same author

Precise control of the interlayer twist angle in large scale MoS<sub>2</sub> homostructures.

Nature communications·2020
Same author

Epidemiological and Genomic Characterization of <i>Campylobacter jejuni</i> Isolates from a Foodborne Outbreak at Hangzhou, China.

International journal of molecular sciences·2020
Same author

A national survey on fungal infection diagnostic capacity in the clinical mycology laboratories of tertiary care hospitals in China.

Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi·2020
Same author

Detection of serum IgM and IgG for COVID-19 diagnosis.

Science China. Life sciences·2020
Same author

MiR-155 inhibition alleviates suppression of osteoblastic differentiation by high glucose and free fatty acids in human bone marrow stromal cells by upregulating SIRT1.

Pflugers Archiv : European journal of physiology·2020

Signal transducer and activator of transcription 3 (STAT3) is frequently activated in many cancers, including melanoma. Targeting STAT3 offers a promising therapeutic strategy by impacting tumor growth, metastasis, and immune evasion.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Signaling

Background:

  • Signal transducer and activator of transcription 3 (STAT3) is a key signaling pathway activated in 50-90% of human cancers.
  • STAT3 plays a critical role in tumor cell survival, proliferation, angiogenesis, metastasis, and immune evasion.
  • Its role in oncogenesis has been extensively studied in melanoma models.

Purpose of the Study:

  • To review the multifaceted role of STAT3 in cancer, with a specific focus on melanoma.
  • To highlight STAT3 as a therapeutic target for various cancers.

Main Methods:

  • Literature review summarizing key studies on STAT3 in cancer and melanoma.
  • Analysis of STAT3's function in regulating genes involved in cancer progression.

Related Experiment Videos

Main Results:

  • STAT3 promotes tumor cell survival and proliferation by regulating target gene expression.
  • STAT3 drives metastasis and angiogenesis via induction of MMP-2 and VEGF.
  • STAT3 contributes to immune evasion by modulating inflammatory and immune-suppressing factors.

Conclusions:

  • Targeting STAT3 offers a multi-pronged therapeutic approach against cancer.
  • Emerging small-molecule inhibitors targeting STAT3 present a novel and promising strategy for melanoma treatment.